Clinical Trial Update: Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Removed by Surgery [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the combination of radiation therapy with cisplatin and etoposide in unresectable non-small cell lung cancer; the study status is termi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Etoposide (Etoposide)

Snippet

Sponsor: University of Washington | Conditions: Recurrent Non-small Cell Lung Cancer, Stage IIB Non-small Cell Lung Cancer | Phase 1 | Status: TERMINATED